Error in Figure. In Figure 3 of the article titled “Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease: A 4-Year Randomized Controlled Trial,” published in the July issue of the ARCHIVES (2004;61:1044-1053), the lines indicating mean change in Unified Parkinson’s Disease Rating Scale activities of daily living scores during pramipexole and levodopa treatments should be reversed. The top line should indicate pramipexole, and the bottom line should indicate levodopa.
Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease: A 4-Year Randomized Controlled Trial—Correction. Arch Neurol. 2005;62(3):430. doi:10.1001/archneur.62.3.430